Sandoz, a global leader in generics, in partnership with Pharmathen, a Greek pharmaceutical company, will launch its biosimilar semaglutide which will help reduce costs for patients paying high prices for branded GLP-1 drugs like Ozempic and Wegovy
Laboratory and mechanistic findings do not always translate into proven clinical benefits for lupus patients
In the UK, it is available in 25 mg, 50 mg, and 100 mg tablets, allowing healthcare providers to tailor the dose to individual needs and tolerability
Stopping permanently is also appropriate when side effects are severe and persistent, when contraindications develop, or when the patient's informed preference is to discontinue after shared decision-making
These syringes come in 0.3ml (30 unit), 0.5ml (50 unit), and 1.0ml (100 unit) sizes